301363.SZ
美好医疗
SZSE · C 制造业 · CN
CNY 16.15
−4.21%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.7B | 1.6B | 1.6B | 1.3B | 1.4B |
| Cost of Revenue | 1.0B | 973.8M | 923.4M | 786.6M | 806.1M |
| Gross Profit | 702.0M | 651.7M | 670.8M | 551.0M | 609.2M |
| Operating Expenses | |||||
| R&D Expense | 137.4M | 133.8M | 140.6M | 120.4M | 87.7M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 129.2M | 123.6M | 107.8M | 101.3M | 84.0M |
| Selling & Marketing Expense | 47.0M | 47.4M | 45.1M | 31.8M | 26.1M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 333.3M | 299.3M | 260.4M | 209.9M | 160.8M |
| Cost and Expenses | 1.4B | 1.3B | 1.2B | 996.5M | 966.9M |
| Operating Income (EBIT) | 333.8M | 325.2M | 410.5M | 351.7M | 456.7M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 333.2M | 324.7M | 410.3M | 351.4M | 456.7M |
| Income Tax Expense | 45.3M | 41.6M | 46.5M | 38.1M | 54.6M |
| Bottom Line | |||||
| Net Income | 287.9M | 283.1M | 363.8M | 313.3M | 402.1M |
| Earnings from Cont. Ops | 287.9M | 283.1M | 363.8M | 313.3M | 402.1M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 287.9M | 283.1M | 363.8M | 313.3M | 402.1M |
| Per Share | |||||
| Basic EPS | CN¥0.51 | CN¥0.50 | CN¥0.64 | CN¥0.77 | CN¥1.08 |
| Diluted EPS | CN¥0.51 | CN¥0.50 | CN¥0.64 | CN¥0.77 | CN¥1.08 |
| Revenue Per Share | CN¥3.06 | CN¥2.87 | CN¥2.80 | CN¥3.29 | CN¥3.80 |
| Shares | |||||
| Basic Shares Outstanding | 566.8M | 566.2M | 568.4M | 406.9M | 372.3M |
| Diluted Shares Outstanding | 566.8M | 566.2M | 568.4M | 406.9M | 372.3M |
| Profitability Metrics | |||||
| EBITDA | — | 432.4M | 510.3M | 436.0M | 519.0M |
| D&A | — | 107.2M | 99.8M | 84.3M | 62.3M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026